Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Munyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, Hadn Africa, Simbarashe Mabwe, Lungisa Jaxa, Nicole Bilek, Alba Llibre, Vincent Rouilly, Mark Hatherill, Matthew Albert, Thomas J. Scriba, Elisa Nemes. T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation. Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018

Member's Comments

No comment yet.

Related content which might interest you: A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis Source: Eur Respir J 2015; 45: 1173-1176 Year: 2015 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10 Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 166s Year: 2003 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum Source: Eur Respir J 2014; 44: 254-257 Year: 2014 Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016 Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019 Year: 2020 Enhanced diagnosis of tuberculosis using a dual gene target detection approach Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 427s Year: 2004 Clinical utility of T-cell-based assay for the diagnosis of extrapulmonary tuberculosis Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017 Performance of five serological tests using different antigens in rapid diagnosis of tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1283 Year: 2006 A new assay for the diagnosis of tuberculosis infection in an unselected population Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods Source: Eur Respir J, 51 (5) 1702189; 10.1183/13993003.02189-2017 Year: 2018 The value of interferon (IFN)-γ blood tests in diagnosis of tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006